Keyphrases
Acute Hypoxemic Respiratory Failure
10%
Acute Phase
21%
Adult Patients
14%
Antibody Level
12%
Antibody Test
12%
Antireceptor
12%
At Discharge
14%
BNT162b2 Vaccine
8%
Chemiluminescent
8%
Clinical Severity
9%
COVID-19
100%
CXCL10
8%
Disease Severity
16%
Disease-specific Mortality
14%
Domain Antibody
14%
Dosing Regimen
14%
Drug Fever
14%
Drug-induced Lymphocyte Stimulation Test
14%
Emerging Variants
9%
Favipiravir
14%
Fever
8%
Hemodialysis Patients
14%
High Incidence
8%
Index Patient
8%
Interleukin-6
10%
Japan
9%
Linezolid
21%
Nasopharyngeal Viral Load
31%
Neutralizing Activity
26%
Neutralizing Antibodies
28%
Omicron Variant
12%
Patients with COVID-19
33%
Positive Drug
14%
Prospective Observational Study
8%
Pseudotyped Virus
9%
Receptor-binding Domain
14%
Reduced Dose
11%
Respiratory Failure
21%
RNAemia
24%
SARS-CoV-2 Infection
12%
SARS-CoV-2 RNAemia
14%
Serum Samples
11%
Severe Progression
14%
Staphylococcus Aureus Bacteremia
14%
Symptomatic Patients
14%
Thrombocytopenia
14%
Transmissibility
14%
Type I Interferon
14%
University Hospital
9%
Viral Load
32%
Immunology and Microbiology
Antibody Response
28%
Blood Level
5%
Booster Dose
7%
Breakthrough Infection
14%
Cell Population
7%
COVID-19
85%
CXCL10
8%
Drug Dose Reduction
5%
Follicular B Helper T Cells
7%
Hemodialysis
14%
Humoral Immunity
6%
Immune Response
5%
Immunity
7%
Immunology
23%
interferon
15%
Interleukin 6
16%
Methicillin-Resistant Staphylococcus Aureus
7%
Minimum Concentration
5%
Neutralization
25%
Neutralizing Antibody
35%
Omicron Coronavirus Variant
24%
Receptor Binding
11%
Severe Acute Respiratory Syndrome Coronavirus 2
55%
Viral Load
48%
Wild Type
19%
Medicine and Dentistry
Antibody Response
7%
Bacterial Infection
7%
Bloodstream Infection
7%
Cell Population
7%
Chemotherapy
7%
Cladosporium
7%
COVID-19
70%
Disease Severity
14%
Glucan
7%
Ground Glass Opacity
7%
Hematology
7%
Hypoxemia
7%
Immunity
7%
Infection
22%
Interferon
8%
Interferon Type I
7%
Interleukin 6
17%
Linear Regression Analysis
7%
Lung Abscess
7%
Methicillin Resistant Staphylococcus Aureus
7%
Methicillin Resistant Staphylococcus Aureus Infection
7%
Nasopharyngeal Swab
7%
Neutralizing Antibody
7%
Nose Smear
5%
Odds Ratio
5%
Omicron Coronavirus Variant
8%
Outpatient
7%
Panton Valentine Leukocidin
7%
Respiratory Failure
21%
Retrospective Study
7%
Sepsis
7%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Systemic Mycosis
7%
T Follicular Helper Cell
7%
Virus Isolation
7%